Healthy Trends Worldwide markets BPS-5 supplement with blood-pressure drug claims, FDA says.
What happened
FDA reviewed the company’s website in October 2022 and its Facebook and YouTube pages, which direct consumers to the website to buy BPS-5. FDA found claims that BPS-5 regulates blood pressure and that its ingredients fight blood pressure, blood disorders, and heart disease. FDA says these claims make BPS-5 a drug, and that it is an unapproved new drug and misbranded.
What FDA found
The website and social media claims show BPS-5 is intended to treat or prevent disease, so FDA treats it as a drug.
section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)]BPS-5 is not generally recognized as safe and effective for these uses, making it an unapproved new drug.
section 201(p) of the Act [21 U.S.C. 321(p)]; sections 301(d) and 505(a) [21 U.S.C. 331(d), 355(a)]The product lacks adequate directions for safe use by a layperson for its intended use.
section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]; 21 CFR 201.5Selling the misbranded drug in interstate commerce violates the Act.
section 301(a) of the Act [21 U.S.C. 331(a)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations, including how it will prevent recurrence and related documentation.
Who should pay attention
- dietary supplement brands that make blood-pressure claims
- online marketers and affiliates promoting supplements
- companies selling disease-treatment claims for supplements
This is a summary. Read the original letter on fda.gov.